Post Operative Cognitive Dysfunction and Delirium After Spinal Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03950557 |
|
Recruitment Status : Unknown
Verified May 2019 by Federico Linassi, University of Padova.
Recruitment status was: Not yet recruiting
First Posted : May 15, 2019
Last Update Posted : May 15, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Emergence Delirium Post-Operative Cognitive Dysfunction |
| Study Type : | Observational |
| Estimated Enrollment : | 200 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Post-Operative Cognitive Dysfunction and Delirium After Spinal Surgery: Incidence and Relation With Common Intraoperative Neuromonitoring Data, Blood Pressure Parameters and Concentration of Propofol and Remifentanil Infused With Targeted Controlled Infusion (TCI ) |
| Estimated Study Start Date : | July 1, 2019 |
| Estimated Primary Completion Date : | October 31, 2020 |
| Estimated Study Completion Date : | December 31, 2020 |
- Incidence of Post-Operative Cognitive Dysfunction in spinal-surgery patients detected with Montreal Cognitive Assessment test [ Time Frame: Patients will be subjected to Montreael Cognitive Assessment (MOCA) test one day before surgery and 1 day after surgery. This test has a score ranging from 1 (minimum) to 30 (maximum). Better neurocognitve outcome with higher scores) ]Discover incidence of Post-Operative Cognitive decline analyzing changes in Post-Operative Cognitive Dysfunction changes between Pre-operative Montreal Cognitive Assessment test score and post-operative Montreal Cognitive Assessment test score
- Incidence of Post-Operative Cognitive Dysfunction in spinal-surgery patients detected with Trail Making Test A and B [ Time Frame: Patients will be subjected to Trail Making Test (TMT) A and B one day before surgery and 1day after surgery. These tests will be evaluated in seconds required to be completed (better neurocognitive outcome with fewer seconds required) ]Discover Post-Operative Cognitive Dysfunction analyzing changes between Pre-operative Trail Making Test A and B test score and post-operative Trail Making Test A and B test score
- Incidence of Post-Operative Cognitive Dysfunction in spinal-surgery patients detected with Digit Span Test [ Time Frame: Patients will be subjected to DST one day before surgery and 1 day after surgery. Better neurocognitve outcome with higher scores ]Discover Post-Operative Cognitive Dysfunction analyzing changes between Pre-operative Digit Span Test score and post-operative Digit Span Test test score
- Incidence of Emergence Delirium in spinal-surgery patients [ Time Frame: Patients will be subjected to CAM 15 minutes after the awakening after general anesthesia ]Discover Emergence Delirium analyzing Post-operative Confusion Assessment Method (CAM) delivered 15 minutes after the awakening of patients
- Incidence of Emergence Delirium in spinal-surgery patients [ Time Frame: Patients will be subjected to CAM 60 minutes after the awakening after general anesthesia ]Discover Emergence Delirium analyzing Post-operative Confusion Assessment Method (CAM) delivered 60 minutes after the awakening of patients
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- General Anaesthesia delivered with Propofol and Remifentanil with Targeted Controlled Infusion
- Surgical duration > 60 minutes
Exclusion Criteria:
- Neurological pathologies
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03950557
| Contact: Federico Linassi, MD | 049 8754256 | federico.linassi@studenti.unipd.it |
| Responsible Party: | Federico Linassi, Principal Investigator, University of Padova |
| ClinicalTrials.gov Identifier: | NCT03950557 |
| Other Study ID Numbers: |
FLUO |
| First Posted: | May 15, 2019 Key Record Dates |
| Last Update Posted: | May 15, 2019 |
| Last Verified: | May 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Infusion pumps Intraoperative brain monitoring |
|
Delirium Emergence Delirium Postoperative Cognitive Complications Cognitive Dysfunction Confusion Neurobehavioral Manifestations Neurologic Manifestations |
Nervous System Diseases Neurocognitive Disorders Mental Disorders Cognition Disorders Postoperative Complications Pathologic Processes |

